InvestorsHub Logo
Followers 4
Posts 372
Boards Moderated 0
Alias Born 08/13/2019

Re: sts66 post# 229268

Thursday, 11/21/2019 2:45:56 PM

Thursday, November 21, 2019 2:45:56 PM

Post# of 425847

No statins have patent protection left except Kowa's Livalo, so no need for AMRN to license a statin patent from anyone. Otherwise, you're correct - GILD wanting to combine V with another drug would require them licensing rights from AMRN - would also extend protection from generic V for that combo use.



Oh! I forgot about that! Good catch :D
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News